The progress and future of enhancing antiviral capacity by transgenic technology in the silkworm Bombyx mori
The progress and future of enhancing antiviral capacity by transgenic technology in the silkworm Bombyx mori
复制标题
家蚕转基因技术增强抗病毒能力的进展与展望
DOI:
10.1016/j.ibmb.2014.02.003
复制
发表时间:
2014-05-01
影响因子:
3.8
通讯作者:
Xia, Qingyou
中科院分区:
文献类型:
--
作者:
Jiang, Liang;Xia, Qingyou
Bombyx marl is a common lepidopteran model and an important economic insect for silk production. B. marl nucleopolyhedrovirus (BmNPV) is a typical pathogenic baculovirus that causes serious economic losses in sericulture. B. mori and BmNPV are a model of insect host and pathogen interaction including invasion of the host by the pathogen, host response, and enhancement of host resistance. The antiviral capacity of silkworms can be improved by transgenic technology such as overexpression of an endogenous or exogenous antiviral gene, RNA interference of the BmNPV gene, or regulation of the immune pathway to inhibit BmNPV at different stages of infection. Antiviral capacity could be further increased by combining different methods. We discuss the future of an antiviral strategy in silkworm, including possible improvement of anti-BmNPV, the feasibility of constructing transgenic silkworms with resistance to multiple viruses, and the safety of transgenic silkworms. The silkworm model could provide a reference for disease control in other organisms. (C) 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license